Notice names this product. Baxter Healthcare’s Dextrose Injection is named in FDA Class I recall D-0850-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution. Identifying details: Lot #: Y495066, Exp. Date July 31, 2027. Units affected: 606 bags. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.
Company / brand: Baxter Healthcare recalls
Affected product: Dextrose Injection recall status
Official ID D-0850-2026 · Official record ↗
See all Baxter Healthcare recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 12:00 PM UTC.